These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27244791)

  • 21. Child and adolescent mental health care in Dutch general practice: time trend analyses.
    Zwaanswijk M; van Dijk CE; Verheij RA
    BMC Fam Pract; 2011 Dec; 12():133. PubMed ID: 22133283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication management of stimulants in pediatric practice settings: a national perspective.
    Hoagwood K; Jensen PS; Feil M; Vitiello B; Bhatara VS
    J Dev Behav Pediatr; 2000 Oct; 21(5):322-31. PubMed ID: 11064959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotropic Medication Prescribing: Youth in Foster Care Compared with Other Medicaid Enrollees.
    Keefe RJ; Cummings ADL; Smith AE; Greeley CS; Van Horne BS
    J Child Adolesc Psychopharmacol; 2023 May; 33(4):149-155. PubMed ID: 37204275
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of psychotropic medications in general paediatric practice.
    Hazell P
    J Paediatr Child Health; 2018 Oct; 54(10):1073-1076. PubMed ID: 30294990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulant Treatment of Young People in the United States.
    Olfson M; King M; Schoenbaum M
    J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):520-6. PubMed ID: 26982632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of behavioral health disorders in pediatric practice.
    Williams J; Klinepeter K; Palmes G; Pulley A; Foy JM
    Pediatrics; 2004 Sep; 114(3):601-6. PubMed ID: 15342827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.
    Pincus HA; Tanielian TL; Marcus SC; Olfson M; Zarin DA; Thompson J; Magno Zito J
    JAMA; 1998 Feb; 279(7):526-31. PubMed ID: 9480363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
    Chen CY; Gerhard T; Winterstein AG
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):187-95. PubMed ID: 19364296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
    Rushton JL; Clark SJ; Freed GL
    Pediatrics; 2000 Jun; 105(6):E82. PubMed ID: 10835095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic.
    Valtuille Z; Acquaviva E; Trebossen V; Ouldali N; Bourmaud A; Sclison S; Gomez A; Revet A; Peyre H; Delorme R; Kaguelidou F
    JAMA Netw Open; 2024 Apr; 7(4):e247965. PubMed ID: 38652474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016.
    Gerlach LB; Kales HC; Kim HM; Zhang L; Strominger J; Covinsky K; Teno J; Bynum JPW; Maust DT
    J Am Geriatr Soc; 2021 Jun; 69(6):1479-1489. PubMed ID: 33683703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mental illness in primary care: a narrative review of patient, GP and population factors that affect prescribing rates.
    Tobin H; Bury G; Cullen W
    Ir J Psychol Med; 2020 Mar; 37(1):59-66. PubMed ID: 30274566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
    Abrams TE; Lund BC; Bernardy NC; Friedman MJ
    Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011.
    Ronsley R; Scott D; Warburton WP; Hamdi RD; Louie DC; Davidson J; Panagiotopoulos C
    Can J Psychiatry; 2013 Jun; 58(6):361-9. PubMed ID: 23768264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of psychotropic medication in patients with emotionally unstable personality disorder under the care of UK mental health services.
    Paton C; Crawford MJ; Bhatti SF; Patel MX; Barnes TR
    J Clin Psychiatry; 2015 Apr; 76(4):e512-8. PubMed ID: 25919844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists.
    Efron D; Hiscock H; Sewell JR; Cranswick NE; Vance AL; Tyl Y; Luk ES
    Pediatrics; 2003 Feb; 111(2):372-5. PubMed ID: 12563066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychotropic medication prescription in U.S. ambulatory medical care.
    Hohmann AA; Larson DB; Thompson JW; Beardsley RS
    DICP; 1991 Jan; 25(1):85-9. PubMed ID: 2008789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.